FrancophonIA/ELRC3.0 huggingface dataset:
English: This latency period is very short even for an alkylating agent.
Maltese: Il-perjodu ta' latency huwa qasir ħafna, anke għal aġent alkylating.
English: Convulsions, consciousness decreased, somnolence, aphasia, balance impaired, dizziness, confusion, memory impairment, concentration impaired, neuropathy, paresthesia, speech disorder, tremor
Maltese: Konvulżjonijiet, tnaqqis tal-konxjetà, ngħas, afażja, telf tal-ekwilibriju, sturdament, konfużjoni, inbdeboliment tal-memorja, indeboliment tal konċentrazzjoni, newropatija, parasteżija, ma jitkellmux tajjeb, tregħid
English: Thrombocyte Count
Maltese: Fażi konkomitanti
English: After oral administration of 14C-labelled TMZ, mean faecal excretion of 14C over 7 days post-dose was 0.8%
Maltese: tikkettat bis-14C, il-medja tal-ammont ta' 14C fl-ippurgar ‘l fuq minn 7 ijiem wara ddoża kienet 0.8% li tindika assorbiment komplet.
English: Temozolomide Teva 180 mg hard capsules Each hard capsule contains 180 mg temozolomide.
Maltese: Temozolomide Teva 180 mg kapsuli ibsin Kull kapsula iebsa fiha 180 mg temozolomide.
English: Visual field defect, vision blurred, diplopia
Maltese: Difett fil-kamp viżiv, vista mċajpra,
English: Dose in Cycle 1 (monotherapy) is 150 mg/m² once daily for 5 days followed by 23 days without treatment.
Maltese: Id-doża f'Ċiklu 1 (monoterapija) hija 150 mg/m² darba kuljum għal 5 ijiem segwiti minn 23 jum mingħajr kura.
English: Table 5 includes adverse reactions reported during clinical trials for recurrent or progressive malignant glioma and following the marketing of TMZ.
Maltese: Tabella 5:Reazzjonijiet avversi f'pazjenti bi glijoma malinna rikurrenti jew progressiva Infezzjonijiet u infestazzjonijiet Rari:
English: Patients in the TMZ + RT arm received concomitant TMZ (75 mg/m²) once daily, starting the first day of RT until the last day of RT, for 42 days (with a maximum of 49 days).
Maltese: Il-pazjenti fil-fergħa ta' TMZ + RT irċevew flimkien TMZ (75 mg/m²) darba kuljum, bdew fl-ewwel jum ta' RT sal-aħħar jum ta' RT għal 42 jum (sa mhux aktar minn 49 jum).
English: Uncommon (may affect up to 1 in 100 people): reduced number of blood cell counts (pancytopenia, anaemia, leukopenia).
Maltese: Mhux komuni (jistgħu jaffettwaw sa persuna waħda minn kull 100): tnaqqis fl-għadd taċ-ċelluli tad-demm (panċitopenija, anemija, lewkopenija).
English: Temozolomide Teva 250 mg hard capsules Each hard capsule contains 250 mg temozolomide.
Maltese: Temozolomide Teva 250 mg kapsuli ibsin Kull kapsula iebsa fiha 250 mg temozolomide.
English: EU/1/09/606/011 5 capsules EU/1/09/606/012 20 capsules
Maltese: EU/1/09/606/011 5 kapsuli EU/1/09/606/012 20 kapsuli
English: Temozolomide Teva 140 mg hard capsules Each hard capsule contains 140 mg temozolomide.
Maltese: Temozolomide Teva 140 mg kapsuli ibsin Kull kapsula iebsa fiha 140 mg temozolomide.
English: This led to hospitalisation and/or discontinuation of TMZ in 8% and 4%, respectively.
Maltese: Minħabba f'hekk kellhom jittieħdu l-isptar u/jew kellu jitwaqqaf TMZ fi 8% u 4%, rispettivament.
English: Your doctor will work out your dose of Temozolomide Teva.
Maltese: Mediċini oħra u Temozolomide Teva
English: Based on an analysis of population pharmacokinetics in phase II trials, co-administration of dexamethasone, prochlorperazine, phenytoin, carbamazepine, ondansetron, H2 receptor antagonists, or phenobarbital did not alter the clearance of TMZ.
Maltese: dexamethasone, prochlorperazine, phenytoin, carbamazepine, ondansetron, antagonisti tar-riċettur tal
English: Each capsule is approximately 19.5 mm in length.
Maltese: Kull kapsula hija twila madwar 19.5 mm.
English: During the concomitant phase, your doctor will start Temozolomide Teva at a dose of 75 mg/m² (usual dose).
Maltese: Waqt il-fażi konkomitanti, it-tabib tiegħek ser jibdielek Temozolomide Teva b'doża ta' 75 mg/m² (doża tas-soltu).
English: Temozolomide Teva 100 mg hard capsules Temozolomide
Maltese: Temozolomide Teva 100 mg kapsuli ibsin Temozolomide
English: Temozolomide Teva 250 mg two stripes in black ink on the cap and “T 250 mg” in black ink on the body
Maltese: Temozolomide Teva 250 mg żewġ strixxi b'linka sewda fuq l għatu u “T 250 mg” b'linka sewda fuq il-korp
English: Meningoencephalitis herpetic
Maltese: 4.1 Indikazzjonijiet terapewtiċi
English: Each hard capsule contains 5 mg temozolomide.
Maltese: Kull kapsula fiha 5 mg, temozolomide.
English: A complete blood count should be obtained on Day 22 (21 days after the first dose) or within 48 hours of that day, and weekly until ANC > 1.5 x 109/l and platelet count > 100 x109/l.
Maltese: Għadd komplet tad-demm għandu jinkiseb fit-22 jum (21 jum wara l-ewwel doża) jew sa 48 siegħa minn dak il-jum, u kull ġimgħa sakemm l-ANC ikun >1.5 x 109/l u l-għadd talplejtlets ikun >100 x 109/l.
English: absolute neutrophil count ≥ 1.5 x 109/l; thrombocyte count ≥ 100 x 109/l; CTC non-haematological toxicity ≤ Grade 1 (except for alopecia, nausea, vomiting).
Maltese: Il-kura b'TMZ mogħti b'mod konkomitanti tista' titkompla meta jintlaħqu dawn ilkondizzjonijiet kollha li ġejjin: għadd assolut tan-newtrofili ≥ 1.5 x 109/l; għadd tattromboċiti ≥ 100 x 109/l; tossiċità mhux ematoloġika ta' CTC ta' ≤ Grad 1 (ħlief għal alopeċja, tqalligħ, rimettar).
English: In a population pharmacokinetics analysis of clinical trial experience there were 101 female and 169 male subjects for whom nadir neutrophil counts were available and 110 female and 174 male subjects for whom nadir platelet counts were available.
Maltese: F'analiżi bil-farmakokinetiċi ta'popolazzjoni fl-esperjenza bi prova klinika kien hemm 101 mara u 169
English: Themedian times to progression in these endpoints ranged from 0.7 to 2.1 months longer for TMZ than for procarbazine (log rank p = < 0.01 to 0.03).
Maltese: Iż-żminijiet medjani għall-progressjoni f'dawn l-endpoints varja minn 0.7 sa 2.1 xhur aktar għal TMZ milli għal procarbazine (log rank p = < 0.01 sa 0.03). Astroċitoma anaplastika rikorrenti
English: Temozolomide Teva 100 mg two stripes in pink ink on the cap and “T 100 mg” in pink ink on the body
Maltese: Temozolomide Teva 100 mg żewġ strixxi b'linka roża fuq lgħatu u “T 100 mg” b'linka roża fuq il-korp
English: Administration of TMZ with food resulted in a 33% decrease in Cmax and a 9% decrease in area under the curve (AUC).
Maltese: L-għoti ta' TMZ mal-ikel irriżulta fi tnaqqis ta' 33% fis-Cmax u fi tnaqqis ta' 9% fl-erja taħt il-kurva
English: Temozolomide Teva 140 mg two stripes in blue ink on the cap and “T 140 mg” in blue ink on the body
Maltese: Temozolomide Teva 140 mg żewġ strixxi b'linka blu fuq l-għatu u “T 140 mg” b'linka blu fuq ilkorp
English: Temozolomide Teva 140 mg hard capsules: (including printing ink): gelatin, titanium dioxide (E171), shellac, propylene glycol, Indigo carmine (E132) aluminium lake Temozolomide Teva 180 mg hard capsules: (including printing ink): gelatin, titanium dioxide (E171), shellac, propylene glycol, red iron oxide (E172)
Maltese: Temozolomide Teva 180 mg kapsuli ibsin: (li tinkudi l-linka tal-istampar): gelatin, titanium dioxide (E171), shellac, propylene glycol, Indigo carmine (E132) aluminium lake, yellow iron oxide (E172).
English: Hepatitis due to hepatitis B virus (HBV) reactivation, in some cases resulting in death, has been reported.
Maltese: Ġiet irrappurtata epatite minħabba l-attivazzjoni mill-ġdid tal-virus tal-epatite B (HBV), li f'xi każijiet irriżultat f'mewt.
English: You will again take Temozolomide Teva once daily for 5 days followed by 23 days without Temozolomide Teva.
Maltese: Ser terġa' tirċievi Temozolomide Teva darba kuljum għal ħamest ijiem, segwit minn 23 jum mingħajr Temozolomide Teva.
English: TMZ is to be discontinued if: dose level -1 (100 mg/m²) still results in unacceptable toxicity the same Grade 3 non-haematological toxicity (except for alopecia, nausea, vomiting) recurs after dose reduction.
Maltese: Livell tad-doża -1 (100 mg/m²) jibqa' jirriżulta f'tossiċità inaċċettabbli L-istess tossiċità mhux ematoloġika ta' Grad 3 (ħlief għal alopeċja, tqalligħ, rimettar) terġa' tiġri wara tnaqqis fid-doża
English: Very rare (may affect up to 1 in 10,000 people): skin redness, urticaria (hives), skin eruption,
Maltese: Rari ħafna (jistgħu jaffettwaw sa persuna waħda minn kull 10,000): ħmura tal-ġilda, urtikarja (ħobżħobz), ponot fil-ġilda, reazzjonijiet allerġiċi.
English: Table 4: Treatment-emergent events during concomitant and monotherapy treatment phases in patients with newly-diagnosed glioblastoma multiforme System organ class
Maltese: Fit-tabelli, l-effetti mhux mixtieqa huma klassifikati skont is-Sistema tal-Klassifika tal-Organi u lfrekwenza.
English: Hepatic injury, including fatal hepatic failure, has been reportedin patients treated with TMZ (see section 4.8).
Maltese: Ħsara fil-fwied, li tinkludi insuffiċjenza fatali tal-fwied, kienet irrappurtata f'pazjenti kkurati b'TMZ (ara sezzjoni 4.8).
English: Dyspnoea, coughing
Maltese: disfaġja, ħalq xott
English: New or reactivated (recurring) cytomegalovirus infections and reactivated hepatitis B virus infections have been uncommonly reported.
Maltese: cytomegalovirus u tal-virus tal-epatite B riattivat.
English: A treatment cycle with Temozolomide Teva lasts 28 days.
Maltese: Ċiklu ta' kura b'Temozolomide Teva jinkludi 28 jum.
English: Convulsions were reported very commonly in the newlydiagnosed glioblastoma multiforme patients receiving monotherapy, and rash was reported very commonly in newly-diagnosed glioblastoma multiforme patients receiving TMZ concurrent with RT and also as monotherapy, and commonly in recurrent glioma.
Maltese: Pazjenti adulti bi glioblastoma multiforme li tkun għadha kif ġiet iddijanjostikata Kura biex tilqa' għat-tqalligħ hija rakkomandata qabel l-ewwel doża tal-fażi konkomitanti u hija rakkomandata ħafna waqt il-fazi b'monoterapija.
English: Temozolomide Teva 5 mg two stripes in green ink on the cap and “T 5 mg” in green ink on the body
Maltese: Temozolomide Teva 5 mg żewġ strixxi b'linka ħadra fuq lgħatu u “T 5 mg” b'linka ħadra fuq il-korp
English: Red iron oxide (E172)
Maltese: Propylene Glycol Iron oxide aħmar (E172)
English: In a separate phase I study, administration of TMZ with ranitidine did not result in alterations in the extent of absorption of temozolomide or the exposure to its active metabolite monomethyl triazenoimidazole carboxamide (MTIC).
Maltese: Interazzjoni ma' prodotti mediċinali oħra u forom oħra ta' interazzjoni Fi studju separat ta' fażi I, l-għoti ta' TMZ ma' ranitidine ma bidilx il-grad ta' assorbiment ta' temozolomide jew l-esponiment għall-metabolit attiv tiegħu monomethyl triazenoimidazole carboxamide (MTIC).
English: Patients with tumours that have returned or worsened (malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma) taking Temozolomide Teva only
Maltese: Pazjenti b'tumuri li reġgħu ħarġu jew aggravaw (glijoma malinna, bħal glioblastoma multiforme jew astroċitoma anaplastika) li qed jieħdu Temozolomide Teva biss:
English: EU/1/09/606/007 5 capsules EU/1/09/606/008 20 capsules
Maltese: EU/1/09/606/007 5 kapsuli EU/1/09/606/008 20 kapsuli
English: Recurrent anaplastic astrocytoma
Maltese: Disturbi gastro-intestinali
English: EU/1/09/606/003 5 capsules EU/1/09/606/004 20 capsules
Maltese: EU/1/09/606/003 5 kapsuli EU/1/09/606/004 20 kapsuli
English: Temozolomide Teva in combination treatment with radiotherapy in newly-diagnosed glioblastoma
Maltese: Informazzjoni dettaljata dwar din il-mediċina tinsab fuq is-sit elettroniku tal-Aġenzija Ewropea għall
English: EU/1/09/606/009 5 capsules EU/1/09/606/010 20 capsules
Maltese: EU/1/09/606/009 5 kapsuli EU/1/09/606/010 20 kapsuli
English: At the start of Cycle 2, the dose is escalated to 200 mg/m² if the CTC nonhaematological toxicity for Cycle 1 is Grade ≤ 2 (except for alopecia, nausea and vomiting), absolute neutrophil count (ANC) is ≥ 1.5 x 109/l, and the thrombocyte count is
Maltese: Fil-bidu ta' Ċiklu 2, id-doża tiżdied għal 200 mg/m² jekk ittossiċità mhux ematoloġika CTC għal Ċiklu 1 huwa Grad ≤ 2 (ħlief għal alopeċja, tqalligħ u rimettar), jekk l-għadd assolut tan-newtrofili (ANC) jkun ≥ 1.5 x 109/l, u l-għadd tat-tromboċiti jkun ≥ 100 x 109/l.
English: TMZ is administered orally at a dose of 75 mg/m² daily for 42 days concomitant with focal radiotherapy (60 Gy administered in 30 fractions).
Maltese: TMZ jingħata b'mod orali b'doża ta' 75 mg/m² kuljum għal 42 jum flimkien ma' radjuterapija fokali (60
English: - if you have had an allergic reaction to dacarbazine (an anticancer medicine sometimes called DTIC).
Maltese: • jekk kellek reazzjoni allerġika għal dacarbazine (kura kontra l-kanċer, kultant imsejħa DTIC).
English: EU/1/09/606/001 5 capsules EU/1/09/606/002 20 capsules
Maltese: EU/1/09/606/001 5 kapsuli EU/1/09/606/002 20 kapsuli
English: Cerebral haemorrhage, hypertension Embolism pulmonary, oedema, oedema peripheral
Maltese: Emorraġija ċerebrali, pressjoni għolja Emboliżmu fil-pulmun, edima,
English: EU/1/09/606/005 5 capsules EU/1/09/606/006 20 capsules
Maltese: EU/1/09/606/005 5 kapsuli EU/1/09/606/006 20 kapsuli
English: Adult and paediatric patients 3 years of age or older with recurrent or progressive malignant glioma A treatment cycle comprises 28 days.
Maltese: Pazjenti adulti u pedjatriċi minn 3 snin 'il fuq bi glijoma malinna rikorrenti jew progressiva
English: Temozolomide Teva is administered in combination with focal radiotherapy (concomitant phase) followed by up to 6 cycles of temozolomide (TMZ) monotherapy (monotherapy phase).
Maltese: l-effetti sekondarji ta' Temozolomide Teva (ara sezzjoni 4), it-tabib tiegħek jista' jordnalek mediċina (anti-emetika) biex tgħinek tevita r-rimettar.
English: Very rare cases of lung side effects have been observed with Temozolomide Teva.
Maltese: Każijiet rari ħafna ta' effetti sekondarji tal-pulmun dehru b'Temozolomide Teva.
English: Printing ink
Maltese: majelosoppressjoni.
English: If ANC falls to < 1.0 x 109/l or the platelet count is < 50 x 109/l during any cycle, the next cycle should be reduced one dose level (see section 4.2).
Maltese: ANC jaqa' għal < 1.0 x 109/l jew l-għadd tal-plejtlets ikun < 50 x 109/l waqt xi ċiklu, iċ-ċiklu li jmiss għandu jitnaqqas b'livell wieħed ta' doża (ara sezzjoni 4.2).
English: Monotherapy phase
Maltese: Fażi ta' monoterapija
English: Convulsions, headache
Maltese: Konvulżjonijiet, uġigħ ta' ras
English: Temozolomide Teva 20 mg hard capsules have a white opaque body and cap with two stripes in orange ink on the cap and with “T 20 mg” in orange ink on the body.
Maltese: Temozolomide Teva 20 mg kapsuli ibsin għandhom korp abjad opak u għatu b'żewġ strixxi b'linka oranġjo fuq l-għatu u b'“T 20 mg” b'linka oranġjo fuq il-korp.
English: Dose reductions and discontinuations during the monotherapy phase should be applied according to Tables 2 and 3.
Maltese: It-tnaqqis u t-twaqqif tad-dożi waqt il-fażi ta' monoterapija għandhom isiru skont f'Tabelli 2 u 3.
English: Temozolomide Teva 250 mg hard capsules have a white opaque body and cap with two stripes in black ink on the cap and with “T 250 mg” in black ink on the body.
Maltese: Temozolomide Teva 250 mg kapsuli ibsin għandhom korp abjad opak u għatu b'żewġ strixxi b'linka sewda fuq l-għatu u b'“T 250 mg” b'linka sewda fuq il-korp.
English: Each hard capsule contains 100 mg temozolomide
Maltese: Kull kapsula iebsa fiha 100 mg ta' temozolomide.
English: The median survival was 7.34 and 5.66 months for TMZ and procarbazine, respectively (log rank p = 0.33).
Maltese: 2.89 u 1.88 xhur rispettivament (log rank p = 0.0063).
English: Experts in liver disease should be consulted before treatment is initiated in patients with positive hepatitis B serology (including those with active disease).
Maltese: Għandhom jiġu kkonsultati esperti fuq mard tal-fwied qabel tinbeda l-kura f'pazjenti b'seroloġija pożittiva għall-epatite B (inkluż dawk b'marda attiva).
English: Febril neutropenia, thrombocytopenia, anaemia, leukopenia
Maltese: tromboċitopenija, anemija,
English: Results of the Ames/salmonella and Human Peripheral Blood Lymphocyte (HPBL) chromosome aberration tests showed a positive mutagenicity response.
Maltese: Uman (HPBL) urew rispons pożittiv għall-mutaġeniċità.
English: EU/2/00/018/001 Incurin 1 mg Tablet
Maltese: EU/2/00/018/001 Incurin
English: 30 tablets
Maltese: 1 mg Pilloli
English: Content
Maltese: Tiżmim
English: Oral use
Maltese: Mhux applikabli
English: Box containing 1 blister
Maltese: Ippakkjar Kontenut Daqs talpakkett
English: EU Number Name Strength Pharmaceutical form
Maltese: Qawwa Għamla Farmaċewtika
English: N/a
Maltese: Mill-ħalq
English: EU/1/96/018/001 Rapilysin
Maltese: EU/1/96/018/001 Rapilysin 10U Trab u solvent għal soluzzjoni għall-injezzjoni
English: 10 U 10 ml (1 U/ml)
Maltese: Solvent: 10 ml
English: 2 vials
Maltese: 2 fjali +
English: 2 prefilled syringes 2 reconstitution devices and 2 needles 19 G l
Maltese: 2 siringi mimlija minn qabel + 2 mezzi għarrikostituzzjoni/labar
English: Powder: vial (glass) Solvent: prefilled syringe (glass)
Maltese: Solvent: siringa mimlija minn qabel (talħġieġ)
English: Intravenous use
Maltese: Isem inventat
English: Finland Orion Oyj Orionintie 1
Maltese: Il-Finlandja Orion Oyj Orionintie 1
English: Genepharm Ae, 18 Km.
Maltese: Genepharm Ae, 18 Km. Leof.
English: Avenida Professor Doutor Cavaco Silva, 10ETaguspark
Maltese: Professor Doutor Cavaco Silva, 10ETaguspark
English: 36396 Stainau an der Strasse
Maltese: 36396 Stainau an der
English: Luxembourg Qualiphar Laboratoire Rijksweg 9
Maltese: Qualiphar Laboratoire Rijksweg 9
English: 1-10 Constantinoupoleos Street, 3011, P.O.
Maltese: 1-10 Constantinoupoleos Street, 3011, P.O. Box
English: & Emp F/Kon-Chem/Kon & Kal.
Maltese: & Emp F/Kon-Chem/Kon &
English: Hungary Teva Gyógyszergyár Zrt.
Maltese: L-Ungerija Teva Gyógyszergyár Zrt.
English: Av. Tomás Ribeiro, 43Bloco 2, 3º F - Edifício Neopark
Maltese: Tomás Ribeiro, 43Bloco 2, 3º F - Edifício Neopark
English: Farmakeytika Proionta Epe,
Maltese: S.M. Farmakeytika Proionta Epe,
English: Romania GEDEON RICHTER ROMÂNIA S.A., ROMANIA
Maltese: Ir-Rumanija GEDEON RICHTER ROMÂNIA S.A., ROMANIA
English: Bulgaria Tchaikapharma Highquality Medicines
Maltese: Il-Bulgarija Tchaikapharma Highquality Medicines
English: 123ratio Sp. z o.o.
Maltese: 123ratio Sp. z o.o. ul.
English: Hungary Pharma-Regist Kft., Október 6. u. 7.
Maltese: L-Ungerija Pharma-Regist Kft., Október 6. u.
English: Finland Oy Leiras Takeda Paciuksenkatu 21
Maltese: Il-Finlandja Oy Leiras Takeda Paciuksenkatu 21
English: Avenida Mestre Cid, 8 - 1º Esq. Frente
Maltese: Avenida Mestre Cid, 8 - 1º Esq.
English: Alexandriei 145 A, B07 Bragadiru,
Maltese: SRL, Sos. Alexandriei 145 A, B07 Bragadiru,
English: Farmaceutici Caber S.P.A. V.Le Citta' D'europa, 681 00100 Roma
Maltese: Farmaceutici Caber S.P.A. V.Le Citta' D'europa, 681 00100
English: Belgium Laboratoria Qualiphar N.V/S.A
Maltese: Laboratoria Qualiphar N.V/S.
English: Biotech Φαρ/Κη Επε Δ.Τ.
Maltese: Biotech Φαρ/Κη Επε Δ.Τ. D.A.S.T.
English: Romania SOLACIUM PHARMA S.R.L., str. Calea Rahovei nr. 266268, corp. 60, axele A-B, stalpii 11-16, etaj II, birou 1, sector 5, Bucuresti
Maltese: Ir-Rumanija SOLACIUM PHARMA S.R.L., str. Calea Rahovei nr. 266268, corp. 60, axele A-B, stalpii 11-16, etaj II, birou 1, sector 5, Bucuresti
English: Denmark Takeda Pharma A/S Dybendal Aile 10
Maltese: Id-Danimarka Takeda Pharma A/S Dybendal Aile 10
English: Al. Jerozolimskie 146 A 02-305 Warszawa Poland
Maltese: Jerozolimskie 146 A 02-305 Warszawa Poland
English: Hungary PannonPharma Kft. Pannonpharma út 1.
Maltese: Kft. Pannonpharma út 1.
English: SIA Briz, Rasas iela 5, Riga,
Maltese: Briz, Rasas iela 5, Riga,
English: Germany 1 A Pharma Keltenring 1 + 3
Maltese: Il-Ġermanja 1 A Pharma Keltenring 1 + 3
English: Bulgaria Nobel Pharma OOD 24 Simeonovsko shose bulvd.
Maltese: Il-Bulgarija Nobel Pharma OOD 24 Simeonovsko shose bulvd.
English: Germany Hexal Aktiengesellschaft Industriestr.25
Maltese: Il-Ġermanja Hexal Aktiengesellschaft Industriestr.25
English: WAAS_ANITA S.A. General Prim 13 28035 Madrid Spain
Maltese: WAAS_ANITA S.A. General Prim 13 28035
English: Romania ANTIBIOTICE SA Str. Valea Lupului nr.1, Iasi 707410,
Maltese: Valea Lupului nr.1, Iasi 707410,
English: Lithuania AS GRINDEKS Krustpils 53
Maltese: Il-Litwanja AS GRINDEKS Krustpils 53
English: ARENA GROUP S.A. Str. Ştefan Mihăileanu nr. 31, Sector 2, Bucureşti, cod postal 024022,
Maltese: Ştefan Mihăileanu nr. 31, Sector 2, Bucureşti, cod postal 024022,
English: Bulgaria Adipharm EAD 130 Simeonovsko Shosse blvd
Maltese: Il-Bulgarija Adipharm EAD 130 Simeonovsko Shosse blvd
English: 1200 Bruxelles
Maltese: 1200 Bruxelles Belgium
English: Avda Osa Mayor, 4 28023 Aravaca Madrid
Maltese: Osa Mayor, 4 28023 Aravaca Madrid
English: Sopharma Warszawa Sp. z o.o.
Maltese: Sopharma Warszawa Sp. z o.o. ul.
English: São Martinho do Bispo 3045-016 Coimbra Portugal
Maltese: São Martinho do Bispo 3045-016 Coimbra Portugal bromhexine
English: Estrada de Paço de Arcos, 88 - Cacém Park, Armazém 27 2735-307 Agualva-Cacém Portugal
Maltese: Estrada de Paço de Arcos, 88 - Cacém Park, Armazém 27 2735-307 Agualva-Cacém Portugal bromhexine
English: Bulgaria Actavis EAD 29 Atanas Dukov str. 1407 Sofia
Maltese: Il-Bulgarija Actavis EAD 29 Atanas Dukov str. 1407 Sofia
English: RATIOPHARM ESPAÑA S.A. Avda Burgos, 16 D 5ª Planta 28036 Madrid
Maltese: ESPAÑA S.A. Avda Burgos, 16 D 5ª Planta 28036 Madrid
English: Avda Bruselas , 24
Maltese: Bruselas , 24
English: Hungary EGIS Gyógyszergyár Zrt., Keresztúri út 30-38.
Maltese: L-Ungerija EGIS Gyógyszergyár Zrt., Keresztúri út 30-38.
English: Germany Pädia Arzneimittel Gruhlstr.
Maltese: Il-Ġermanja Pädia Arzneimittel Gruhlstr.
English: Luxembourg D.J.VAN TINTELEN BEHEER B.V.
Maltese: D.J.VAN TINTELEN BEHEER B.V.
English: The Star Medicines Importers & Co Ltd
Maltese: The Star Medicines Importers & Co
English: G. L. Pharma GmbH, Schlossplatz 1, 8502 Lannach,
Maltese: L. Pharma GmbH, Schlossplatz 1, 8502 Lannach,
English: Tseti Far/Ka Ergastiria Abee, Kalyftaki 27, 14561 Kifissia, Attiki, Greece
Maltese: & Eir. Tseti Far/Ka Ergastiria Abee, Kalyftaki 27, 14561 Kifissia, Attiki, Greece
English: Luxembourg Eurogenerics Heizel Esplanade b22 1020 Brussel
Maltese: Eurogenerics Heizel Esplanade b22 1020
English: Lithuania EGIS PHARMACEUTICALS PLC
Maltese: Is-Slovakkja EGIS Pharmaceuticals PLC
English: Romania Egis Pharmaceuticals Plc Kereszturi ut 30-38
Maltese: Ir-Rumanija Egis Pharmaceuticals Plc Kereszturi ut 30-38
English: 8 mg/ml 1,5 mg/ml 0,75 mg/ml mg/ml mg/ml mg/ml mg/ml oral drops
Maltese: 8 mg/ml 1,5 mg/ml 0,75 mg/ml mg/ml mg/ml mg/ml mg/ml qtar orali
English: Angelini Pharma Hellas Anonimi Biomhxaniki Etaireia Paragogis & Emporias Farmakon, Achaias & Trizinias, 14564, N. Kiffisia, Greece
Maltese: Angelini Pharma Hellas Anonimi Biomhxaniki Etaireia Paragogis & Emporias Farmakon, Achaias & Trizinias, 14564, N.
English: 7,5mg/5ml, 0,0001g oral liquid
Maltese: 7,5mg/5ml, 0,0001g likwidu orali
English: Ireland Teva Pharma B.V. Computerweg 10
Maltese: Teva Pharma B.V. Computerweg 10
English: Cuatro amigos 7, escalera 2, 1ºD
Maltese: DESMA LABORATORIO FARMACEUTICO, S.L. Cuatro amigos 7, escalera 2, 1ºD
English: Germany Wick Pharma Zweigniederlassung Procter & Gamble GmbH Sulzbacher Str. 40
Maltese: Il-Ġermanja Wick Pharma Zweigniederlassung Procter & Gamble GmbH Sulzbacher Str. 40
English: Takeda Pharma Sp. z o.o.
Maltese: Takeda Pharma Sp. z o.o. Al.
English: Germany Heumann Pharma GmbH&Co.KG Generica KG Südwestpark 50
Maltese: Il-Ġermanja Heumann Pharma GmbH&Co.KG Generica KG Südwestpark 50
English: Rua Aquilino Ribeiro, 6-A 2790-027 Carnaxide Portugal
Maltese: Rua Aquilino Ribeiro, 6-A 2790-027 Carnaxide Portugal ambroxol
English: Pr. Abee, L. Fylis 137, 13451 Kamatero Attikis, Greece
Maltese: Kal. Pr. Abee, L. Fylis 137, 13451 Kamatero Attikis, Greece
English: Laboratórios Basi - Indústria Farmacêutica, S.A Parque Industrial Manuel Lourenço Ferreira, Lote 15 3450-232 Mortágua Portugal
Maltese: Laboratórios Basi - Indústria Farmacêutica, S.A Parque Industrial Manuel Lourenço Ferreira, Lote 15 3450-232 Mortágua Portugal bromhexine
English: Germany acis Arzneimittel GmbH Lil-Dagover-Ring 7
Maltese: Il-Ġermanja acis Arzneimittel GmbH Lil-Dagover-Ring 7
English: Rua Sebastião e Silva, 25 2745-838 Massamá Portugal
Maltese: Rua Sebastião e Silva, 25 2745-838 Massamá Portugal ambroxol